CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

about

CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.

P2860

Q40118769-0A5AA6BE-8494-4132-B1F2-D011E9F65183 Q55496770-34AB2A20-7633-4BE2-B514-2F848C2A9275

P2860

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q40376093

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

@en

type

Item

label

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

@en

prefLabel

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

@en

P1476

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

@en

P2093

Chihiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Iekuni Oh

http://www.w3.org/2001/XMLSchema#string

Kaoru Hatano

http://www.w3.org/2001/XMLSchema#string

Kazuo Muroi

http://www.w3.org/2001/XMLSchema#string

Kazuya Sato

http://www.w3.org/2001/XMLSchema#string

Keiya Ozawa

http://www.w3.org/2001/XMLSchema#string

Ken Ohmine

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Okazuka

http://www.w3.org/2001/XMLSchema#string

Shin-Ichiro Fujiwara

http://www.w3.org/2001/XMLSchema#string

Takahiro Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.

Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells.

Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.

The role of interleukin-2 receptor alpha in cancer.

CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.

Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.

Acute myeloid leukemia in older adults.

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

Acute myeloid leukemia and myelodysplastic syndromes in older adults.

P304

347-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2016.1276240

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28097942

http://www.w3.org/2001/XMLSchema#string

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

about

P2860

P2860

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698